Causes Analysis of Acute Upper Gastrointestinal Bleeding in One Case of Postoperative Patients with PCI
- VernacularTitle:1例经皮冠脉动脉介入治疗术后患者急性上消化道出血原因分析
- Author:
Qing ZHOU
;
Aiping DENG
;
Yi WANG
;
Jue LIU
- Keywords:
Antiplatelet drugs;
PCI perioperative period;
Perioperative period;
Acute upper gastrointestinal bleeding;
Rational drug use;
Clinical pharmacist
- From:
China Pharmacist
2017;20(3):522-524
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the role of clinical pharmacists in the use of antiplatelet drugs in the patients with PCI in periop-erative period in order to improve the clinical treatment effect and reduce the incidence of adverse drug reactions. Methods:According to the latest antiplatelet drug treatment guidelines and the related literatures, the causes of acute upper gastrointestinal bleeding induced by triple antiplatelet drugs were analyzed in one case of postoperative patients with PCI, and the rationality of the drug use and the treatment of bleeding were discussed, and the related suggestions were put forward for clinics. Results:In order to ensure the clinical safety and the rational use of drugs, the patients with high risk of bleeding and high thrombosis events should carefully select new anti-platelet drugs, and anti ischemic drugs with good efficacy and low bleeding risk were the first choices. Conclusion:In order to ensure medication safety and effectiveness, clinical pharmacists should actively participate in clinical rational drug use through giving relative suggestions and playing active roles in the rational use of antiplatelet drugs.
